Company intelligence / Profile preview

Risen-Sun Pharmaceutical

Nanjing, Jiangsu, China

Ownership: Private
Employees: ~500
Development stage: Other

Overview

Risen-Sun Pharmaceutical is a China-based pharmaceutical company focused on the research, development, and commercialization of innovative drugs and high-quality generics. The company maintains a diverse portfolio spanning oncology, cardiovascular, and anti-infective therapeutic areas. Risen-Sun is particularly recognized for its efforts in developing targeted therapies for cancer, including small molecule inhibitors and biologics. With integrated capabilities in R&D and manufacturing, the company aims to provide affordable and effective treatment options for patients globally.

Therapeutic areas: Infectious DiseasesCardiovascularOncology
Modalities: Small moleculeMonoclonal antibody
Industry: Biotech

Drug pipeline

1 asset

W1302

Unknown

Beyond the preview

Go deeper on Risen-Sun Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Risen-Sun Pharmaceutical.

Explore the full profile